Will we be singing a different tune on combined post- and pre-capillary pulmonary hypertension?

被引:3
作者
Hsu, Steven [1 ]
Tedford, Ryan J. [2 ]
机构
[1] Johns Hopkins Univ, Cardiol, Baltimore, MD USA
[2] Med Univ South Carolina, Coll Med, Charleston, SC 29425 USA
关键词
CHRONIC HEART-FAILURE; PHOSPHODIESTERASE-5; INHIBITION; ARTERIAL-HYPERTENSION; EJECTION FRACTION; EXERCISE CAPACITY; SILDENAFIL; MORBIDITY; MORTALITY; GRADIENT; TRIAL;
D O I
10.1183/13993003.02589-2017
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
[No abstract available]
引用
收藏
页数:3
相关论文
共 24 条
  • [1] Clinical and Biological Insights Into Combined Post- and Pre-Capillary Pulmonary Hypertension
    Assad, Tufik R.
    Hemnes, Anna R.
    Larkin, Emma K.
    Glazer, Andrew M.
    Xu, Meng
    Wells, Quinn S.
    Farber-Eger, Eric H.
    Sheng, Quanhu
    Shyr, Yu
    Harrell, Frank E.
    Newman, John H.
    Brittain, Evan L.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 68 (23) : 2525 - 2536
  • [2] Hemodynamic evidence of vascular remodeling in combined post- and precapillary pulmonary hypertension
    Assad, Tufik R.
    Brittain, Evan L.
    Wells, Quinn S.
    Farber-Eger, Eric H.
    Halliday, Stephen J.
    Doss, Laura N.
    Xu, Meng
    Wang, Li
    Harrell, Frank E.
    Yu, Chang
    Robbins, Ivan M.
    Newman, John H.
    Hemnes, Anna R.
    [J]. PULMONARY CIRCULATION, 2016, 6 (03) : 313 - 321
  • [3] A randomized controlled trial of epoprostenol therapy for severe congestive heart failure: The Flolan International Randomized Survival Trial (FIRST)
    Califf, RM
    Adams, KF
    McKenna, WJ
    Gheorghiade, M
    Uretsky, BF
    McNulty, SE
    Darius, H
    Schulman, K
    Zannad, F
    HandbergThurmond, E
    Harrell, FE
    Wheeler, W
    SolerSoler, J
    Swedberg, K
    [J]. AMERICAN HEART JOURNAL, 1997, 134 (01) : 44 - 54
  • [4] Cheli Martino, 2015, F1000Prime Rep, V7, P07, DOI 10.12703/P7-07
  • [5] Pulmonary vascular remodeling in pulmonary hypertension due to chronic heart failure
    Delgado, JF
    Conde, E
    Sánchez, V
    López-Rios, F
    Gómez-Sánchez, MA
    Escribano, P
    Sotelo, T
    de la Cámara, AG
    Cortina, J
    de la Calzada, CS
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2005, 7 (06) : 1011 - 1016
  • [6] MORTALITY AND MORBIDITY IN PATIENTS RECEIVING ENCAINIDE, FLECAINIDE, OR PLACEBO - THE CARDIAC-ARRHYTHMIA SUPPRESSION TRIAL
    ECHT, DS
    LIEBSON, PR
    MITCHELL, LB
    PETERS, RW
    OBIASMANNO, D
    BARKER, AH
    ARENSBERG, D
    BAKER, A
    FRIEDMAN, L
    GREENE, HL
    HUTHER, ML
    RICHARDSON, DW
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1991, 324 (12) : 781 - 788
  • [7] Galie N, 2015, EUR HEART J, V2015, DOI 10.1093/eur-heartj/ehv317
  • [8] Diastolic Pulmonary Vascular Pressure Gradient A Predictor of Prognosis in "Out-of-Proportion" Pulmonary Hypertension
    Gerges, Christian
    Gerges, Mario
    Lang, Marie B.
    Zhang, Yuhui
    Jakowitsch, Johannes
    Probst, Peter
    Maurer, Gerald
    Lang, Irene M.
    [J]. CHEST, 2013, 143 (03) : 758 - 766
  • [9] The effects of phosphodiesterase-5 inhibition with sildenafil on pulmonary hemodynamics and diffusion capacity, exercise ventilatory efficiency, and oxygen uptake kinetics in chronic heart failure
    Guazzi, M
    Tumminello, G
    Di Marco, F
    Fiorentini, C
    Guazzi, MD
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 44 (12) : 2339 - 2348
  • [10] Long-term use of sildenafil in the therapeutic management of heart failure
    Guazzi, Marco
    Samaja, Michele
    Arena, Ross
    Vicenzi, Marco
    Guazzi, Maurizio D.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2007, 50 (22) : 2136 - 2144